Skip to content

Effectiveness of Telerehabilitation for Work-Related Musculoskeletal Disorders in Cardiac Sonographers

Effectiveness of Telerehabilitation in the Management of Work-Related Musculoskeletal Disorders in Cardiac Sonographers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06842485
Enrollment
32
Registered
2025-02-24
Start date
2025-03-01
Completion date
2025-06-10
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Work Related Musculoskeletal Disorders

Keywords

work related musculoskeletal disorders, cardiac sonographers, tele rehabilitation

Brief summary

Work-related musculoskeletal disorders(WRMDs) are common among cardiac sonographers due to their nature of work. This study aims to find out the effectiveness of the telerehabilitation method in the management of WRMDs among cardiac sonographers. 38 cardiac sonographers diagnosed with WRMDs will be randomly allocated into experimental and control groups with an allocation ratio1:1. The Experimental group will be receiving the telerehabilitation program along with an ergonomic awareness education program for 6 weeks, and the control group will receive an ergonomic awareness education alone. Pain, quality of life and work satisfaction are the outcome measures which will be measured at the baseline and after 6 weeks of the program

Interventions

OTHERTelerehabilitation

The experimental group will be given a tailored program of telerehabilitation consisting of stretching and strengthening exercises for six weeks (three times per week)

OTHERPatient education

Patient education will be given to both the experimental and control groups. Patient education and telerehabilitation will be given to the experimental group. To the control group, patient education alone will be provided

Sponsors

Imam Abdulrahman Bin Faisal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Cardiac sonographers with work-related musculoskeletal pain. * Cardiac sonographers practicing adult echocardiography predominantly working in public hospitals, private hospitals or/and private outpatient clinics in Saudi Arabia.

Exclusion criteria

* Systematic diseases as reported by the participants such as Diabetes Miletus and Fibromyalgia. * Using cardiac medications or the pain killer as reported by the participants. * Any biomechanical abnormalities based on the evaluation of a qualified physical therapist. * Any other musculoskeletal disorders or injuries which is not related to WRMDs. * Any recent surgery which may affect the ability to participate in the exercise program. * Any other contraindications to participate in the exercise program. * Pregnancy in female participants.

Design outcomes

Primary

MeasureTime frameDescription
Pain measured by Numeric Pain Rating Scalebaseline and immediately after 6 weeks of the programNumeric Pain Rating Scale is a 11-point scale where the minimum score is 0 (indicating no pain) and the maximum score is 10 (representing the worst possible pain)
Quality of life measured by Short Form (36) Health Survey questionnairebaseline and immediately after 6 weeks of the program* The Short Form (36) Health Survey questionnaire contains 36 items that cover eight distinct health domains: * Physical Functioning * Role Limitations due to Physical Health * Role Limitations due to Emotional Problems * Energy/Fatigue (Vitality) * Emotional Wellbeing (Mental Health) * Social Functioning * Pain (Bodily Pain) * General Health Perceptions * Each domain is scored on a scale from 0 to 100. * Higher scores indicate better perceived health and quality of life.
Work satisfactionbaseline and immediately after 6 weeks of the programWork satisfaction measured by The job satisfaction scale

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026